ESC Premium Access

Heart Failure-Wii study

Topic: CHF - Non pharmacological treatment

Presentation

About the speaker

Professor Tiny Jaarsma

Linkoping University, Linkoping (Sweden)
28 presentations
1 follower

5 more presentations in this session

Heart failure and death in new users of SGLT2 inhibitors vs other glucose-lowering drugs - consistent risk reduction across patient groups in 4 countries and >270,000 patients: The CVD-REAL Study

Speaker: Professor A. Norhammar (Stockholm, SE)

Thumbnail

Efficacy of beta-blockers in heart failure according to left ventricular ejection fraction: An individual patient level analysis of double-blind randomised trials

Speaker: Professor D. Kotecha (Birmingham, GB)

Thumbnail

Marked variation in the efficacy of beta-blockers across cardiovascular health: A Global systematic assessment of mortality, myocardial infarction and stroke

Speaker: Doctor O. Ziff (Birmingham, GB)

Thumbnail

Does the risk for heart failure (HF) modulate the effectiveness of empagliflozin on HF hospitalisation or CV death in patients with type 2 diabetes without HF? Insights from EMPA-REG OUTCOME

Speaker: Professor J. Butler (Jackson, US)

Thumbnail

Predicting right heart failure after implantation of continuous flow left ventricular assist devices (EUROMACS-RHF) score: analysis of the EUROMACS data

Speaker: Professor O. Soliman (Galway, IE)

Thumbnail

Access the full session

Late-Breaking Science in Heart Failure

Speakers: Professor T. Jaarsma, Professor A. Norhammar, Professor D. Kotecha, Doctor O. Ziff, Professor J. Butler...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk